New tool 'can determine breast cancer options'
Scientists have developed a new tool that is able to determine what types of treatment will be best for a patient with breast cancer, it has been announced.
Called DyNeMo, the technology was unveiled by researchers at Mount Sinai Hospital in Toronto and published in the journal Nature Biotechnology.
It works by analysing protein networks in cancer cells, after research found that these are differently organised in patients who survive the disease.
After clinicians use the tool to predict the outcome of the subject, they can make "informed decisions" regarding treatment, the team of scientists said.
"This research brings us one step closer to delivering individualised medicine in which healthcare professionals will be able to provide more accurate and personalised diagnoses and treatments," explained director of research for the Samuel Lununfeld Research Institute at the hospital, Dr Jim Woodgett.
Meanwhile, the results of a study were released today, claiming that the risk of ductal and lobular breast cancer is increased with the use of progesterone and oestrogen compared to oestrogen only.
The research was published by the American Cancer Society in its journal.
Adfero Ltd provides live and tailored breaking industry news for Chartis Direct. All industry news is prepared by Adfero Ltd and as such does not represent the views or opinions of Chartis Direct a trading name of UNAT Direct Insurance Management Limited.
© Adfero Ltd 2008
